What is NYMTH's earnings per share (EPS)?

NYMTH (NYMTH) reported diluted earnings per share of $1.10 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

NYMTH Financials

NYMTH

FY2025 annual

Revenue $601.9M +50.0% YoY

Net Income $149.0M +340.3% YoY

EPS (Diluted) $1.10 YoY not available

Free Cash Flow $125.9M +1290.3% YoY

Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported May 1, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q1 FY2026, filed May 1, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the NYMTH SEC filings page.

NYMTH (NYMTH) reported $601.9M in revenue for fiscal year 2025, up 50.0% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI NYMTH FY2025 2026-08-30

Rapid balance-sheet expansion is paired with thin asset returns, while FY2025 earnings finally converted into cash.

From FY2023 to FY2025, total assets expanded from $7.4B to $12.6B without comparable scale in profitability. ROA moved from -0.7% to only 1.2%, indicating that balance-sheet growth has not yet translated into proportionate returns.

In FY2025, cash conversion was relatively close: net income reached $149M while operating cash flow reached $134M. Free cash flow of $126M alongside only $8M of capital expenditure suggests reported cash generation was not mainly consumed by reinvestment.

Liabilities rose from $7.8B in FY2024 to $11.2B in FY2025, so expansion was funded predominantly through obligations rather than retained equity. The liability-heavy structure is easy to understate because debt-to-equity was only 0.5x; that ratio does not capture the full financing burden represented by total liabilities.

Financial Health Signals

Financial health score not available

NYMTH does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial

6/7

NYMTH passes 6 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 3 of 4 profitability signals pass, all 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Mixed

0.90x

For every $1 of reported earnings, NYMTH generates $0.90 in operating cash flow ($134.0M OCF vs $149.0M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Interest Coverage At Risk

0.30x

NYMTH earns $0.30 in operating income for every $1 of interest expense ($137.8M vs $452.6M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$172.1M

YoY+32.6%

QoQ+0.8%

5Y CAGR+28.0%

10Y CAGR+7.7%

NYMTH generated $172.1M in revenue in Q1 2026. This represents an increase of 32.6% from the same quarter a year earlier. Against the prior quarter it is up 0.8%.

EBITDA

$91.3M

YoY+109.5%

QoQ+48.1%

NYMTH's EBITDA was $91.3M in Q1 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 109.5% from the same quarter a year earlier. Against the prior quarter it is up 48.1%.

Net Income

$48.6M

YoY+15.3%

QoQ-9.2%

5Y CAGR-1.4%

10Y CAGR+11.1%

NYMTH reported $48.6M in net income in Q1 2026. This represents an increase of 15.3% from the same quarter a year earlier. Against the prior quarter it is down 9.2%.

EPS (Diluted)

$0.40

YoY+21.2%

NYMTH earned $0.40 per diluted share (EPS) in Q1 2026. This represents an increase of 21.2% from the same quarter a year earlier.

Cash & Balance Sheet

Cash & Debt

$208.9M

YoY+18.0%

QoQ-0.7%

5Y CAGR-6.4%

10Y CAGR+18.0%

NYMTH held $208.9M in cash against $669.5M in long-term debt as of Q1 2026.

Dividends Per Share

$0.23

YoY+15.0%

QoQ0.0%

5Y CAGR-10.5%

10Y CAGR-0.4%

NYMTH paid $0.23 per share in dividends in Q1 2026. This represents an increase of 15.0% from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding

90M

YoY-0.5%

QoQ-0.7%

5Y CAGR-25.0%

10Y CAGR-1.9%

NYMTH had 90M shares outstanding in Q1 2026. This represents a decrease of 0.5% from the same quarter a year earlier. Against the prior quarter it is down 0.7%.

Free Cash Flow

Not reported for Q1 2026.

Margins & Returns

Operating Margin

50.4%

YoY+21.3pp

QoQ+17.4pp

NYMTH's operating margin was 50.4% in Q1 2026, reflecting core business profitability. This is up 21.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 17.4 percentage points.

Net Margin

28.2%

YoY-4.2pp

QoQ-3.1pp

10Y change+7.5pp

NYMTH's net profit margin was 28.2% in Q1 2026, showing the share of revenue converted to profit. This is down 4.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 3.1 percentage points.

Return on Equity

3.3%

YoY+0.3pp

QoQ-0.4pp

5Y change+1.1pp

10Y change+1.4pp

NYMTH's ROE was 3.3% in Q1 2026, measuring profit generated per dollar of shareholder equity. This is up 0.3 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.4 percentage points.

Gross Margin

Not reported for Q1 2026.

Capital Allocation

Share Buybacks

$5.0M

NYMTH spent $5.0M on share buybacks in Q1 2026, returning capital to shareholders by reducing shares outstanding.

R&D Spending

Not reported for Q1 2026.

Capital Expenditures

Not reported for Q1 2026.

NYMTH Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

NYMTH quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Revenue	$644.3M	$601.9M+50.0%	$401.3M+55.1%	$258.7M+0.1%	$258.4M+24.9%	$206.9M-40.9%	$350.2M-49.6%	$694.6M+52.4%	$455.8M+24.5%	$366.1M+14.7%	$319.3M-5.2%	$336.8M-11.1%	$378.8M+29.9%	$291.7M+112.4%	$137.3M	N/A
SG&A Expenses	$84.7M	$72.7M+49.3%	$48.7M-1.8%	$49.6M-5.5%	$52.4M+7.2%	$48.9M+15.8%	$42.2M+18.0%	$35.8M+28.4%	$27.9M-32.1%	$41.1M+16.6%	$35.2M-10.8%	$39.5M-2.4%	$40.5M+103.1%	$19.9M+74.3%	$11.4M+8.6%	$10.5M
Operating Income	$186.8M	$137.8M+248.3%	-$92.9M-19.5%	-$77.7M+77.1%	-$340.1M-278.1%	$190.9M+166.5%	-$287.3M-266.6%	$172.5M+66.3%	$103.7M+12.9%	$91.9M	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA	N/A	$160.9M+403.1%	-$53.1M0.0%	-$53.1M+75.1%	-$213.3M-201.5%	$210.2M+173.3%	-$286.9M-266.3%	$172.5M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$479.7M	$452.6M+42.6%	$317.4M+65.2%	$192.1M+48.5%	$129.4M+63.2%	$79.3M-64.5%	$223.1M-60.6%	$566.8M+50.3%	$377.1M+22.4%	$308.1M+21.0%	$254.7M+1753.9%	$13.7M+146.7%	$5.6M-16.3%	$6.7M+82.6%	$3.6M-24.6%	$4.8M
Income Tax	-$344K	$145K-86.0%	$1.0M+1281.3%	$75K-86.2%	$542K-77.9%	$2.5M+150.6%	$981K+334.1%	-$419K+60.4%	-$1.1M-131.5%	$3.4M+8.4%	$3.1M-31.8%	$4.5M-29.1%	$6.4M+765.4%	$739K-20.7%	$932K+115.2%	$433K
Net Income	$155.5M	$149.0M+340.3%	-$62.0M-27.5%	-$48.7M+83.7%	-$298.6M-254.6%	$193.2M+167.0%	-$288.5M-266.1%	$173.7M+68.9%	$102.9M+11.9%	$92.0M+36.2%	$67.6M-13.4%	$78.0M-42.7%	$136.2M+97.5%	$69.0M+143.8%	$28.3M+492.1%	$4.8M
EPS (Basic)	N/A	$1.12+198.2%	-$1.14-15.2%	-$0.99+72.6%	-$3.61-337.5%	$1.52+270.8%	-$0.89-236.9%	$0.65+4.8%	$0.62-8.8%	$0.68+36.0%	$0.50-19.4%	$0.62-58.1%	$1.48+33.3%	$1.11+2.8%	$1.08+134.8%	$0.46
EPS (Diluted)	—	$1.10	-$1.14-15.2%	-$0.99	-$3.61	$1.51	-$0.89-239.1%	$0.64	$0.61-7.6%	$0.66+32.0%	$0.50-19.4%	$0.62-58.1%	$1.48+33.3%	$1.11	$1.08	$0.46
Diluted Shares (Avg)	N/A	92M	91M-0.2%	91M	94M	95M	371M+52.9%	243M	147M+13.1%	130M+18.9%	110M+1.1%	108M+23.4%	88M+48.7%	59M	26M	10M

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Revenue	$172.1M+32.6%	$170.7M+44.3%	$160.6M+48.2%	$140.9M+55.2%	$129.7M+54.6%	$118.3M+50.1%	$108.4M+66.2%	$90.8M+57.8%
SG&A Expenses	$24.5M+97.3%	$25.1M+108.7%	$23.3M+95.5%	$11.8M+1.2%	$12.4M-4.9%	$12.0M+2.5%	$11.9M+1.0%	$11.6M-12.5%
Operating Income	$86.7M+130.0%	$56.3M+277.1%	$39.5M-7.7%	$4.3M+118.0%	$37.7M+147.0%	-$31.8M-196.8%	$42.8M+145.6%	-$23.7M+23.0%
EBITDA	$91.3M+109.5%	$61.7M+347.6%	$45.4M-10.8%	$10.2M+188.7%	$43.6M+164.5%	-$24.9M-163.7%	$50.9M+158.0%	-$11.5M+53.4%
Interest Expense	$123.7M+28.0%	$127.5M+39.3%	$124.0M+40.8%	$104.5M+45.6%	$96.6M+46.4%	$91.5M+47.7%	$88.1M+82.1%	$71.7M+69.2%
Income Tax	$159K-75.5%	-$44K+97.1%	-$298K-112.8%	-$161K-147.1%	$648K+683.8%	-$1.5M-1242.9%	$2.3M+4251.8%	$342K+2000.0%
Net Income	$48.6M+15.3%	$53.5M+270.5%	$44.8M+4.6%	$8.5M+154.8%	$42.2M+172.8%	-$31.4M-174.9%	$42.8M+150.7%	-$15.6M+42.1%
EPS (Basic)	$0.41+24.2%	N/A	$0.360.0%	-$0.04+86.2%	$0.33+144.0%	N/A	$0.36+134.6%	-$0.29+29.3%
EPS (Diluted)	$0.40+21.2%	N/A	$0.360.0%	-$0.04+86.2%	$0.33	N/A	$0.36+134.6%	-$0.29+29.3%
Diluted Shares (Avg)	92M+1.1%	N/A	92M+1.1%	90M-0.7%	91M	N/A	91M-0.4%	91M-0.2%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses.

NYMTH Balance Sheet

NYMTH quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Total Assets	$12.6B+37.1%	$9.2B+24.5%	$7.4B+18.6%	$6.2B+10.3%	$5.7B+21.5%	$4.7B-80.2%	$23.5B+59.3%	$14.7B+22.2%	$12.1B+34.7%	$9.0B-1.2%	$9.1B-14.1%	$10.5B+6.5%	$9.9B+38.2%	$7.2B+948.8%	$682.7M
Cash & Equivalents	$210.3M+25.6%	$167.4M-10.5%	$187.1M-23.5%	$244.7M-15.5%	$289.6M-1.2%	$293.2M+146.9%	$118.8M+14.5%	$103.7M+9.0%	$95.2M+13.9%	$83.6M+34.9%	$62.0M-18.0%	$75.6M+137.7%	$31.8M+0.1%	$31.8M+91.6%	$16.6M
Goodwill	$22.4M	$0	N/A	N/A	N/A	$0-100.0%	$25.2M0.0%	$25.2M0.0%	$25.2M0.0%	$25.2M	$0	N/A	N/A	N/A	N/A
Total Liabilities	$11.2B+43.6%	$7.8B+35.2%	$5.8B+31.9%	$4.4B+35.6%	$3.2B+37.4%	$2.3B-89.0%	$21.3B+57.0%	$13.6B+22.4%	$11.1B+36.8%	$8.1B-0.9%	$8.2B-15.9%	$9.7B+3.2%	$9.4B+37.7%	$6.8B+1046.6%	$596.4M
Long-Term Debt	$735.8M+28.4%	$573.2M-38.6%	$934.1M+72.2%	$542.5M-45.8%	$1.0B+355.3%	$220.0M-1.6%	$223.6M+4.4%	$214.3M-10.9%	$240.4M	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$1.4B+2.3%	$1.4B-11.7%	$1.6B-10.6%	$1.8B-24.5%	$2.3B+1.7%	$2.3B+4.3%	$2.2B+87.0%	$1.2B+21.4%	$971.9M+14.6%	$848.1M-3.7%	$880.5M+7.7%	$817.9M+70.2%	$480.7M+49.3%	$322.0M+277.6%	$85.3M
Retained Earnings	-$1.4B+1.5%	-$1.4B-14.1%	-$1.3B-19.1%	-$1.1B-88.2%	-$559.3M-1.5%	-$551.3M-270.3%	-$148.9M-44.3%	-$103.2M-36.3%	-$75.7M-21.1%	-$62.5M-439.9%	-$11.6M-135.5%	$32.6M	N/A	-$51.6M+35.4%	-$79.9M

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Total Assets	$12.8B+27.9%	$12.6B+37.1%	$12.4B+39.3%	$10.6B+28.2%	$10.0B+34.3%	$9.2B+24.5%	$8.9B+28.4%	$8.2B+31.1%
Cash & Equivalents	$208.9M+18.0%	$210.3M+25.6%	$185.3M-5.0%	$160.4M-31.9%	$177.1M-22.0%	$167.4M-10.5%	$195.1M-14.6%	$235.5M+1.3%
Goodwill	$22.4M	$22.4M	$22.4M	N/A	N/A	$0	N/A	N/A
Total Liabilities	$11.3B+32.0%	$11.2B+43.6%	$11.0B+47.9%	$9.2B+35.4%	$8.6B+44.8%	$7.8B+35.2%	$7.4B+39.7%	$6.8B+49.5%
Long-Term Debt	$669.5M+2.3%	$735.8M+28.4%	$766.6M+9.6%	$653.0M-18.4%	$654.4M-34.6%	$573.2M-38.6%	$699.4M+28.5%	$800.7M+47.0%
Total Equity	$1.5B+3.9%	$1.4B+2.3%	$1.4B-3.7%	$1.4B-3.5%	$1.4B-5.6%	$1.4B-11.7%	$1.4B-8.3%	$1.4B-15.3%
Retained Earnings	-$1.4B+1.8%	-$1.4B+1.5%	-$1.4B-4.3%	-$1.4B-4.0%	-$1.4B-5.8%	-$1.4B-14.1%	-$1.4B-8.3%	-$1.4B-21.1%

Not reported in any period shown, so not listed: Current Assets, Short-Term Investments, Inventory, Accounts Receivable, Long-Term Investments, Current Liabilities, Non-Current Liabilities.

NYMTH Cash Flow Statement

NYMTH quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Operating Cash Flow	$91.5M	$134.0M+852.6%	$14.1M-53.0%	$30.0M-67.4%	$91.8M-33.9%	$138.9M+25.4%	$110.8M+215.5%	$35.1M+45.2%	$24.2M-17.6%	$29.3M-45.5%	$53.8M+48.2%	$36.3M-3.2%	$37.6M-29.6%	$53.3M+83.2%	$29.1M+116.9%	$13.4M
Depreciation & Amortization	N/A	$23.1M-41.9%	$39.8M+61.7%	$24.6M-80.6%	$126.8M+558.8%	$19.3M+4887.0%	$386K	$0	N/A	N/A	N/A	N/A	-$2.7M-119.9%	$13.4M+28.0%	$10.5M+84.5%	$5.7M
Stock-Based Compensation	N/A	$8.2M+35.1%	$6.1M-31.2%	$8.8M-25.8%	$11.9M+16.2%	$10.2M+3.2%	$9.9M+84.9%	$5.4M+107.9%	$2.6M+58.2%	$1.6M+217.5%	$514K-47.7%	$983K-16.7%	$1.2M+31.5%	$897K+8.6%	$826K+293.3%	$210K
Capital Expenditures	N/A	$8.2M-66.9%	$24.6M-51.1%	$50.4M-75.9%	$209.4M+354.6%	$46.1M+22258.7%	$206K+60.9%	$128K-72.0%	$457K+54.4%	$296K	$0	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	$125.9M+1290.3%	-$10.6M+48.3%	-$20.5M+82.6%	-$117.6M-226.6%	$92.9M-16.0%	$110.5M+216.1%	$35.0M+47.4%	$23.7M-18.3%	$29.0M-46.1%	$53.8M	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$2.2B	-$2.9B-29.1%	-$2.2B-84.0%	-$1.2B-139.8%	-$508.8M-282.7%	-$132.9M-106.3%	$2.1B+375.4%	-$769.1M-19.7%	-$642.5M-46.0%	-$439.9M-738.9%	$68.9M-72.5%	$250.5M+300.4%	-$125.0M+17.9%	-$152.3M+85.7%	-$1.1B-1019.1%	-$95.3M
Financing Cash Flow	$2.2B	$2.8B+24.6%	$2.2B+95.6%	$1.1B+147.7%	$460.1M+1578.6%	$27.4M+101.3%	-$2.0B-374.1%	$746.4M+20.2%	$621.2M+64.7%	$377.3M+672.4%	-$65.9M+80.3%	-$333.9M-354.4%	$131.3M+32.6%	$99.0M-90.6%	$1.1B+1230.8%	$79.1M
Dividends Paid	$78.5M	$75.5M+0.7%	$74.9M-41.8%	$128.8M-15.1%	$151.8M+0.1%	$151.6M+43.7%	$105.5M-35.4%	$163.4M+66.8%	$97.9M+4.3%	$93.9M	N/A	N/A	N/A	N/A	$22.3M+169.7%	$8.3M
Share Buybacks	$6.5M	$1.5M-57.0%	$3.5M-59.5%	$8.6M-80.6%	$44.4M	$0	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Operating Cash Flow	-$16.7M-164.7%	$62.1M+113.2%	$6.9M+850.7%	$39.2M+4049.5%	$25.8M+296.6%	$29.1M+122.6%	-$922K-103.2%	-$993K-883.2%
Depreciation & Amortization	$4.6M-21.6%	$5.4M-22.0%	$5.9M-27.0%	$5.9M-51.5%	$5.9M-53.1%	$6.9M+10.1%	$8.1M+31.1%	$12.2M+99.7%
Stock-Based Compensation	$175K-79.7%	N/A	N/A	N/A	$861K	N/A	N/A	N/A
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	$3.5M-38.4%	$7.6M-35.5%	$7.6M-49.0%
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	$25.7M+243.5%	-$8.6M-151.8%	-$8.6M+42.7%
Investing Cash Flow	-$67.0M+91.6%	-$148.1M+74.7%	-$1.6B-91.2%	-$360.0M+37.1%	-$794.2M-212.7%	-$584.3M-47.0%	-$834.1M-10.0%	-$572.1M-371.8%
Financing Cash Flow	$106.7M-85.0%	$130.6M-76.3%	$1.6B+102.6%	$313.5M-43.1%	$713.8M+118.1%	$552.2M+53.6%	$798.8M+8.0%	$550.5M+344.6%
Dividends Paid	$21.4M+16.0%	$20.8M+14.8%	$18.1M-0.2%	$18.2M-0.4%	$18.5M-9.8%	$18.1M-33.4%	$18.1M-33.8%	$18.2M-50.1%
Share Buybacks	$5.0M	$0	$0	$1.5M-57.0%	$0	$0	$0-100.0%	$3.5M

NYMTH Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

NYMTH quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Operating Margin	22.9%+46.1pp	-23.2%+6.9pp	-30.0%	-131.6%	92.3%+174.3pp	-82.0%-106.9pp	24.8%+2.1pp	22.8%-2.3pp	25.1%	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	24.8%+40.2pp	-15.5%+3.4pp	-18.8%	-115.6%	93.4%+175.8pp	-82.4%-107.4pp	25.0%+2.4pp	22.6%-2.6pp	25.1%+4.0pp	21.2%-2.0pp	23.2%-12.8pp	35.9%+12.3pp	23.6%+3.0pp	20.6%	N/A
Return on Equity	10.4%+14.9pp	-4.5%-1.4pp	-3.1%+13.8pp	-16.9%-25.1pp	8.3%+20.8pp	-12.5%-20.4pp	7.9%-0.8pp	8.7%-0.7pp	9.5%+1.5pp	8.0%-0.9pp	8.9%-7.8pp	16.7%+2.3pp	14.3%+5.6pp	8.8%+3.2pp	5.6%
Return on Assets	1.2%+1.8pp	-0.7%0.0pp	-0.7%+4.1pp	-4.8%-8.2pp	3.4%+9.6pp	-6.2%-6.9pp	0.7%0.0pp	0.7%-0.1pp	0.8%0.0pp	0.8%-0.1pp	0.9%-0.4pp	1.3%+0.6pp	0.7%+0.3pp	0.4%-0.3pp	0.7%
Debt-to-Equity	0.52+0.1x	0.41-0.2x	0.59+0.3x	0.31-0.1x	0.43+0.3x	0.100.0x	0.10-0.1x	0.18-0.1x	0.25-9.3x	9.55+0.3x	9.29-2.6x	11.89-7.7x	19.59-1.6x	21.24+14.2x	6.99
Asset Turnover	0.050.0x	0.040.0x	0.030.0x	0.040.0x	0.040.0x	0.080.0x	0.030.0x	0.030.0x	0.030.0x	0.040.0x	0.040.0x	0.040.0x	0.030.0x	0.02	N/A
FCF Margin	20.9%+23.6pp	-2.6%+5.3pp	-7.9%+37.6pp	-45.5%-90.4pp	44.9%+13.3pp	31.6%+26.5pp	5.0%-0.2pp	5.2%-2.7pp	7.9%-8.9pp	16.9%	N/A	N/A	N/A	N/A	N/A

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Operating Margin	50.4%+21.3pp	33.0%+59.9pp	24.6%-14.9pp	3.0%+29.2pp	29.1%+124.6pp	-26.9%-68.6pp	39.5%	-26.2%+27.4pp
Net Margin	28.2%-4.2pp	31.4%+57.9pp	27.9%-11.6pp	6.1%+23.2pp	32.5%+101.5pp	-26.5%-79.7pp	39.5%	-17.2%+29.6pp
Return on Equity	3.3%+0.3pp	3.8%+6.0pp	3.2%+0.2pp	0.6%+1.7pp	3.0%+6.9pp	-2.3%-4.9pp	3.0%+8.3pp	-1.1%+0.5pp
Return on Assets	0.4%0.0pp	0.4%+0.8pp	0.4%-0.1pp	0.1%+0.3pp	0.4%+1.2pp	-0.3%-0.9pp	0.5%+1.7pp	-0.2%+0.2pp
Debt-to-Equity	0.460.0x	0.52+0.1x	0.55+0.1x	0.47-0.1x	0.47-0.2x	0.41-0.2x	0.48+0.1x	0.56+0.2x
Asset Turnover	0.010.0x	0.010.0x	0.010.0x	0.010.0x	0.010.0x	0.010.0x	0.010.0x	0.010.0x
FCF Margin	N/A	N/A	N/A	N/A	N/A	21.7%+12.2pp	-7.9%-33.3pp	-9.4%+16.5pp

Not reported in any period shown, so not listed: Gross Margin, Current Ratio.

Where NYMTH Ranks

Frequently Asked Questions

What is NYMTH's annual revenue?

NYMTH (NYMTH) reported $601.9M in total revenue for fiscal year 2025. This represents a 50.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is NYMTH's revenue growing?

NYMTH (NYMTH) revenue grew by 50.0% year-over-year, from $401.3M to $601.9M in fiscal year 2025.

Is NYMTH profitable?

Yes, NYMTH (NYMTH) reported a net income of $149.0M in fiscal year 2025, with a net profit margin of 24.8%.

What is NYMTH's EBITDA?

NYMTH (NYMTH) had EBITDA of $160.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does NYMTH have?

As of fiscal year 2025, NYMTH (NYMTH) had $210.3M in cash and equivalents against $735.8M in long-term debt.

What is NYMTH's operating margin?

NYMTH (NYMTH) had an operating margin of 22.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is NYMTH's net profit margin?

NYMTH (NYMTH) had a net profit margin of 24.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is NYMTH's return on equity (ROE)?

NYMTH (NYMTH) has a return on equity of 10.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is NYMTH's free cash flow?

NYMTH (NYMTH) generated $125.9M in free cash flow during fiscal year 2025. This represents a 1290.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is NYMTH's operating cash flow?

NYMTH (NYMTH) generated $134.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are NYMTH's total assets?

NYMTH (NYMTH) had $12.6B in total assets as of fiscal year 2025, including both current and long-term assets.

What are NYMTH's capital expenditures?

NYMTH (NYMTH) invested $8.2M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Does NYMTH buy back shares?

Yes, NYMTH (NYMTH) spent $1.5M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does NYMTH have outstanding?

NYMTH (NYMTH) had 90M shares outstanding as of fiscal year 2025.

What is NYMTH's debt-to-equity ratio?

NYMTH (NYMTH) had a debt-to-equity ratio of 0.52 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is NYMTH's return on assets (ROA)?

NYMTH (NYMTH) had a return on assets of 1.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is NYMTH's Piotroski F-Score?

NYMTH (NYMTH) has a Piotroski F-Score of 6 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are NYMTH's earnings high quality?

NYMTH (NYMTH) has an earnings quality ratio of 0.90x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can NYMTH cover its interest payments?

NYMTH (NYMTH) has an interest coverage ratio of 0.30x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.